Special Episode: A Discussion on the Emerging Concept of Fetal Fentanyl SyndromeSpecial Episode: A Discussion on the Emerging Concept of Fetal Fentanyl Syndrome
Addiction Medicine: Beyond the Abstract
Clinicians and researchers discuss early data on the proposed fetal fentanyl syndrome, contrasting large surveillance findings with a focused case series. They emphasise caution, stigma awareness, and the importance of opioid use disorder treatment, particularly before pregnancy.
42:54•10 Jul 2026
Fetal Fentanyl Syndrome: Early Evidence, Ethics, and Pregnancy Care
Episode Overview
- Current evidence shows some rare anomalies in fentanyl‑exposed infants, but consistent clustering into a clear syndrome has not been demonstrated.
- Researchers stress that fetal fentanyl syndrome remains a proposed concept and may be better described as a spectrum with variable phenotypes.
- High levels of polysubstance use, tobacco exposure and unknown adulterants make it difficult to attribute causation to fentanyl alone.
- Premature conclusions risk fuelling stigma and punitive responses; the guests argue for trauma‑informed, anti‑stigma, patient‑centred care.
- Medications for opioid use disorder, especially started before pregnancy, are highlighted as crucial for prevention and better outcomes for parent–infant dyads.
“We need to be patient with the science so that we can not jump to a conclusion that may have potentially quite significant public health and stigma consequences.”
Ever wondered what it takes to turn early, uncertain research into something that can truly help families affected by addiction? This special episode of *Addiction Medicine: Beyond the Abstract* brings together four clinicians and researchers who are right at the centre of that effort. You’ll hear Dr Carla Marienfeld guide a thoughtful conversation with Dr Marcella Smid, Dr Tanner Wright and Dr Elizabeth Luba Mirsky about the emerging idea of "fetal fentanyl syndrome" and what current data can—and can’t—say.
They walk through two key papers: a large multi‑site surveillance study of over 5,000 mother–infant pairs with opioid use disorder, and a focused case series from a single Kentucky institution. The group spell out that some physical features, such as microcephaly and cleft palate, appear slightly more often in fentanyl‑exposed infants, but each finding is rare and rarely clusters as a clear syndrome.
As Dr Marienfeld summarises, "we need to be patient with the science so that we can not jump to a conclusion that may have potentially quite significant public health and stigma consequences." Dr Mirsky stresses that what’s being discussed is still only a proposed syndrome and suggests it may ultimately be better understood as a spectrum rather than a single fixed pattern. A major thread running through the conversation is stigma and ethics.
Dr Wright highlights the risk that premature conclusions could fuel punitive policies instead of treatment, arguing that "healthy and thriving parents are going to have the healthy and thriving kids." The guests repeatedly emphasise the importance of medications for opioid use disorder, particularly before pregnancy, and call for careful, anti‑stigma, trauma‑informed care. If you’re interested in addiction medicine, pregnancy care, or how early research shapes public health, you’ll find this discussion both cautious and compelling.
It might leave you asking: how can your own practice or perspective support treatment rather than blame?
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.